| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


* Clinical Professor and Immediate Past Chairman, California College of Podiatric Medicine; private practice San Francisco and Santa Rosa, CA. Mailing address: 2281 Cleveland Ave, Santa Rosa, CA 95403.
Submitted during second-year residency, Memorial Hospital of Rhode Island, Brown University, Pawtucket, RI.
Associate Clinical Professor, University of California, San Francisco School of Medicine, San Francisco, CA.
Abstract
The authors evaluate nonsurgical and surgical approaches to treating patients with hemophilic arthropathy and review the functional and economic limitations imposed on treating these patients. Indications for surgery are discussed and a case study that incorporates both conservative and surgical management options is presented. While the advent of factor replacement therapy has dramatically changed the course of treatment and prognosis for patients with hemophilia, the authors argue that the economic burden of treating these patients is still very high. The authors recommend that proper conservative and surgical management options for patients with hemophilia should be based upon a thorough understanding of the disease process. (J Am Podiatr Med Assoc 91(8): 406-414, 2001)
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |